Responses
Original research
Mid-regional proadrenomedullin (MR-proADM), C-reactive protein (CRP) and other biomarkers in the early identification of disease progression in patients with COVID-19 in the acute NHS setting
Compose a Response to This Article
Other responses
No responses have been published for this article.